Items where authors include "Harvey, M"

Article

Harvey, M, Hastings, D and Chowdhury, G (2023) Understanding the costs and challenges of the digital divide through UK council services. Journal of Information Science, 49 (5). pp. 1153-1167. ISSN 0165-5515

Brown, JE, Royle, K-L orcid.org/0000-0003-0225-1199, Gregory, W et al. (96 more authors) (2023) Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. The Lancet Oncology, 24 (3). pp. 213-227. ISSN 1470-2045

Khoo, SH, FitzGerald, R, Saunders, G et al. (87 more authors) (2022) Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial. The Lancet Infectious Diseases. ISSN 1473-3099

Evans, RA, Leavy, OC, Richardson, M et al. (1003 more authors) (2022) Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. The Lancet Respiratory Medicine, 10 (8). pp. 761-775. ISSN 2213-2600

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Vöhringer, HS, Sanderson, T, Sinnott, M orcid.org/0000-0002-3054-7846 et al. (930 more authors) (2021) Genomic reconstruction of the SARS-CoV-2 epidemic in England. Nature, 600 (7889). pp. 506-511. ISSN 0028-0836

de Silva, TI orcid.org/0000-0002-6498-9212, Liu, G, Lindsey, BB orcid.org/0000-0003-4227-2592 et al. (1010 more authors) (2021) The impact of viral mutations on recognition by SARS-CoV-2 specific T cells. iScience, 24 (11). 103353. ISSN 2589-0042

Haza, KZ, Martin, HL, Rao, A et al. (18 more authors) (2021) RAS-inhibiting biologics identify and probe druggable pockets including an SII-α3 allosteric site. Nature Communications, 12. 4045. ISSN 2041-1723

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Breeze, TD, Bailey, AP, Balcombe, KG et al. (22 more authors) (2021) Pollinator Monitoring More than Pays for Itself. Journal of Applied Ecology, 58 (1). pp. 44-57. ISSN 0021-8901

Schuddeboom, A, Varma, V, McDonald, AJ et al. (5 more authors) (2019) Cluster‐Based Evaluation of Model Compensating Errors: A Case Study of Cloud Radiative Effect in the Southern Ocean. Geophysical Research Letters, 46 (6). pp. 3446-3453. ISSN 0094-8276

Dennis, M, Mead, G, Forbes, J et al. (1294 more authors) (2019) Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. The Lancet, 393 (10168). pp. 265-274. ISSN 0140-6736